Ardent Health (NYSE:ARDT) Shares Gap Down – What’s Next?

Ardent Health, Inc. (NYSE:ARDT) gapped down before the market opened on Friday . The stock had previously closed at $9.68, but opened at $9.30. Ardent Health shares last traded at $9.4050, with a volume of 94,718 shares.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on ARDT shares. Leerink Partners reduced their price target on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, March 9th. Zacks Research raised shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings restated a “sell (d)” rating on shares of Ardent Health in a research note on Monday, December 29th. Finally, JPMorgan Chase & Co. dropped their price objective on Ardent Health from $12.00 to $11.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 20th. Seven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Ardent Health presently has a consensus rating of “Hold” and a consensus price target of $14.25.

Ardent Health Trading Down 1.1%

The firm has a fifty day moving average of $9.24 and a two-hundred day moving average of $10.07. The company has a market cap of $1.37 billion, a PE ratio of 9.98 and a beta of 0.57. The company has a current ratio of 1.97, a quick ratio of 1.85 and a debt-to-equity ratio of 0.64.

Ardent Health (NYSE:ARDT) last released its quarterly earnings data on Wednesday, March 4th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.35 by ($0.03). The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.63 billion. Ardent Health had a net margin of 2.15% and a return on equity of 14.30%. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. As a group, sell-side analysts predict that Ardent Health, Inc. will post 1.11 EPS for the current year.

Institutional Trading of Ardent Health

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Caitong International Asset Management Co. Ltd lifted its holdings in Ardent Health by 1,177.7% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock worth $25,000 after purchasing an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank bought a new stake in shares of Ardent Health during the third quarter valued at about $61,000. Monetary Solutions Ltd purchased a new stake in shares of Ardent Health in the fourth quarter worth about $79,000. KLP Kapitalforvaltning AS bought a new position in shares of Ardent Health in the third quarter valued at approximately $80,000. Finally, New York State Common Retirement Fund grew its stake in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock valued at $85,000 after acquiring an additional 3,400 shares in the last quarter.

Ardent Health Company Profile

Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.

Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.